Responses
Clinical and epidemiological research
Extended report
Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomes
Compose a Response to This Article
Other responses
No responses have been published for this article.